# KBS Real Estate Investment Trust III, Inc.: financial statements, quarterly

KBSR · OTC · CIK 1482430 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kbsr.md) · [Financials](/companies/kbsr/financials.md) · [Filings](/companies/kbsr/filings.md) · [Insiders](/companies/kbsr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kbsr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4.7](/filings/0001482430-24-000062.md) | [4.8 d](/filings/0001482430-26-000014.md) | [4.3](/filings/0001482430-25-000036.md) | [4.7](/filings/0001482430-25-000042.md) | [4.6](/filings/0001482430-25-000054.md) | [4.6 d](/filings/0001482430-26-000014.md) | [3.9](/filings/0001482430-26-000021.md) | [4.5](/filings/0001482430-26-000026.md) | [4.2](/filings/0001482430-25-000054.md) | [4.1 d](/filings/0001482430-26-000014.md) | [3.9](/filings/0001482430-26-000021.md) | [4.0](/filings/0001482430-26-000026.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [31.1](/filings/0001482430-24-000062.md) | [33.3 d](/filings/0001482430-26-000014.md) | [32.5](/filings/0001482430-25-000036.md) | [33.2](/filings/0001482430-25-000042.md) | [32.1](/filings/0001482430-25-000054.md) | [28.9 d](/filings/0001482430-26-000014.md) | [28.3](/filings/0001482430-26-000021.md) | [30.5](/filings/0001482430-26-000026.md) | [29.1](/filings/0001482430-25-000054.md) | [26.3 d](/filings/0001482430-26-000014.md) | [25.0](/filings/0001482430-26-000021.md) | [24.4](/filings/0001482430-26-000026.md) |
| Net income | $m | [(23.1)](/filings/0001482430-24-000062.md) | [(23.9) d](/filings/0001482430-26-000014.md) | [37.6](/filings/0001482430-25-000036.md) | [(28.6)](/filings/0001482430-25-000042.md) | [(38.5)](/filings/0001482430-25-000054.md) | [18.7 d](/filings/0001482430-26-000014.md) | [(33.3)](/filings/0001482430-26-000021.md) | [(22.4)](/filings/0001482430-26-000026.md) | [(4.2)](/filings/0001482430-25-000054.md) | [(18.9) d](/filings/0001482430-26-000014.md) | [(12.0)](/filings/0001482430-26-000021.md) | [(39.5)](/filings/0001482430-26-000026.md) |
| Diluted EPS | $ per share | [(0.16)](/filings/0001482430-24-000062.md) | not reported | [0.25](/filings/0001482430-25-000036.md) | [(0.19)](/filings/0001482430-25-000042.md) | [(0.26)](/filings/0001482430-25-000054.md) | not reported | [(0.22)](/filings/0001482430-26-000021.md) | [(0.15)](/filings/0001482430-26-000026.md) | [(0.03)](/filings/0001482430-25-000054.md) | not reported | [(0.08)](/filings/0001482430-26-000021.md) | [(0.27)](/filings/0001482430-26-000026.md) |
| Basic EPS | $ per share | [(0.16)](/filings/0001482430-24-000062.md) | not reported | [0.25](/filings/0001482430-25-000036.md) | [(0.19)](/filings/0001482430-25-000042.md) | [(0.26)](/filings/0001482430-25-000054.md) | not reported | [(0.22)](/filings/0001482430-26-000021.md) | [(0.15)](/filings/0001482430-26-000026.md) | [(0.03)](/filings/0001482430-25-000054.md) | not reported | [(0.08)](/filings/0001482430-26-000021.md) | [(0.27)](/filings/0001482430-26-000026.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [33.1](/filings/0001482430-23-000052.md) | [36.8](/filings/0001482430-25-000021.md) | [34.2](/filings/0001482430-24-000035.md) | [42.2](/filings/0001482430-24-000051.md) | [31.5](/filings/0001482430-24-000062.md) | [30.5](/filings/0001482430-26-000014.md) | [30.1](/filings/0001482430-25-000036.md) | [27.5](/filings/0001482430-25-000042.md) | [30.1](/filings/0001482430-25-000054.md) | [23.7](/filings/0001482430-26-000026.md) | [43.1](/filings/0001482430-26-000021.md) | [26.6](/filings/0001482430-26-000026.md) |
| Total assets | $m | [2,147](/filings/0001482430-23-000052.md) | [2,139](/filings/0001482430-25-000021.md) | [2,008](/filings/0001482430-24-000035.md) | [1,986](/filings/0001482430-24-000051.md) | [1,959](/filings/0001482430-24-000062.md) | [1,823](/filings/0001482430-26-000014.md) | [1,801](/filings/0001482430-25-000036.md) | [1,783](/filings/0001482430-25-000042.md) | [1,594](/filings/0001482430-25-000054.md) | [1,563](/filings/0001482430-26-000026.md) | [1,516](/filings/0001482430-26-000021.md) | [1,479](/filings/0001482430-26-000026.md) |
| Total liabilities | $m | [1,854](/filings/0001482430-23-000052.md) | [1,872](/filings/0001482430-25-000021.md) | [1,703](/filings/0001482430-24-000035.md) | [1,709](/filings/0001482430-24-000051.md) | [1,721](/filings/0001482430-24-000062.md) | [1,567](/filings/0001482430-26-000014.md) | [1,577](/filings/0001482430-25-000036.md) | [1,582](/filings/0001482430-25-000042.md) | [1,397](/filings/0001482430-25-000054.md) | [1,385](/filings/0001482430-26-000026.md) | [1,350](/filings/0001482430-26-000021.md) | [1,352](/filings/0001482430-26-000026.md) |
| Long-term debt | $m | [1,715](/filings/0001482430-23-000052.md) | [1,736](/filings/0001482430-25-000021.md) | [1,573](/filings/0001482430-24-000035.md) | [1,589](/filings/0001482430-24-000051.md) | [1,590](/filings/0001482430-24-000062.md) | [1,443](/filings/0001482430-26-000014.md) | [1,448](/filings/0001482430-25-000036.md) | [1,458](/filings/0001482430-25-000042.md) | [1,279](/filings/0001482430-25-000054.md) | [1,283](/filings/0001482430-26-000026.md) | [1,237](/filings/0001482430-26-000021.md) | [1,240](/filings/0001482430-26-000026.md) |
| Shareholders' equity | $m | [254](/filings/0001482430-23-000052.md) | [267](/filings/0001482430-25-000021.md) | [305](/filings/0001482430-24-000035.md) | [276](/filings/0001482430-24-000051.md) | [238](/filings/0001482430-24-000062.md) | [257](/filings/0001482430-26-000014.md) | [223](/filings/0001482430-25-000036.md) | [201](/filings/0001482430-25-000042.md) | [197](/filings/0001482430-25-000054.md) | [178](/filings/0001482430-26-000026.md) | [166](/filings/0001482430-26-000021.md) | [126](/filings/0001482430-26-000026.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [25.5 d](/filings/0001482430-24-000062.md) | [4.4 d](/filings/0001482430-26-000014.md) | [1.9](/filings/0001482430-25-000036.md) | [5.8 d](/filings/0001482430-25-000042.md) | [(0.8) d](/filings/0001482430-25-000054.md) | [0.8 d](/filings/0001482430-26-000014.md) | [(5.7)](/filings/0001482430-26-000021.md) | [6.4 d](/filings/0001482430-26-000026.md) | [2.8 d](/filings/0001482430-25-000054.md) | [(9.6) d](/filings/0001482430-26-000014.md) | [16.7](/filings/0001482430-26-000021.md) | [0.2 d](/filings/0001482430-26-000026.md) |
| Dividends paid | $m | [3.5 d](/filings/0001482430-24-000062.md) | [(0.0) d](/filings/0001482430-26-000014.md) | [0.0](/filings/0001482430-24-000035.md) | [0.0 d](/filings/0001482430-24-000051.md) | [0.0 d](/filings/0001482430-24-000062.md) | [0.0 d](/filings/0001482430-26-000014.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [3.3 d](/filings/0001482430-24-000062.md) | [2.1 d](/filings/0001482430-26-000014.md) | [0.0](/filings/0001482430-24-000035.md) | [0.0 d](/filings/0001482430-24-000051.md) | [0.0 d](/filings/0001482430-24-000062.md) | [0.0 d](/filings/0001482430-26-000014.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [147](/filings/0001482430-23-000052.md) | [148](/filings/0001482430-24-000035.md) | [149](/filings/0001482430-24-000051.md) | [149](/filings/0001482430-24-000062.md) | [149](/filings/0001482430-25-000036.md) | [149](/filings/0001482430-25-000042.md) | [149](/filings/0001482430-25-000054.md) | [149](/filings/0001482430-26-000021.md) | [149](/filings/0001482430-26-000026.md) | [149](/filings/0001482430-25-000054.md) | [149](/filings/0001482430-26-000021.md) | [149](/filings/0001482430-26-000026.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 148,516,246 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001482430-26-000026.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.